Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5415-5417

  Singh, Amar ^a   Jones, Richard F ^a   Friedman, Henry ^a   Hathir, Shahendeh ^a   Soos, Gyorgyike ^a   Zabo, Andras ^a   Haas, Gabriel P ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bladder cancer; p53; pRb; Prostate cancer

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PROSTATIC NEOPLASMS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0033389843     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Landis SH, Murray T, Bolden S and Wingo PA: Cancer Statistics, 1999. CA Cancer J Clin 49: 8-31, 1999.
2. Melicow MW and Uson AC: Multiple unrelated primary malignancies of the genitourinary tract. J Urol 77: 96, 1945.
3. Barbaian RJ, Troncoso P and Ayala A: Transurethal-resection zone prostate cancer detected at cystoprostatectomy. A detailed histologic analysis and clinical implications. Cancer 67: 1418-1422, 1991.
4. Pritchett TR, Moreno J, Warner NE, Lieskovsky G, Nichols PW, Cook BA and Skinner DG: Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. J Urol 139: 1214-1216, 1988.
5. Mahadevia PS, Koss LG and Tar IJ: Prostatic involvement in bladder cancer. Prostate mapping in 20 cystoprostatectomy specimens. Cancer 58: 2096-2102, 1986.
6. Montie JE, Wood DP Jr, Pontes JE, Boyett JM and Levin HS: Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 63: 381-385, 1989.
7. Villers A, McNeal JE, Freiha FS and Stamey TA: Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 70: 2313-2318, 1992.
8. Pawlish KS, Schottenfeld D, Severson R and Montie JE: Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study. Prostate 33: 75-86, 1997.
9. Wegner HE, Meier T, Klan R and Dieckmann KP: Bladder cancer following prostate cancer - an analysis of risk factors. Int Urol Nephrol 26: 43-51, 1994.
10. Liskow AS, Neugut AI, Benson M, Olsson CA, Birkhoff J and Chang CH: Multiple primary neoplasms in association with prostate cancer in black and white patients. Cancer 59: 380-384, 1987.
11. Chun TY: Coincidence of bladder and prostate cancer. J Urol 157: 65-67, 1997.
12. Grossman HB, Liebert M, Antelo M, Dinney CP, Hu SX, Palmer JL and Benedict WF: p53 and Rb expression predict progression in T1 bladder cancer. Clin Cancer Res 4: 829-834, 1998.
13. Burkhard FC, Markwalder R, Thalmann GN and Studer UE: Immunohistochemical determination of p53 overexpression. An easy and readily available method to identify progression in superficial bladder cancer? Urol Res 25 (Suppl 1): S31-35, 1997.
14. Kallakury BV, Figge J, Ross JS, Fisher HA, Figge HL and Jennings TA: Association of p53 immunoreactivity with high gleason tumor grade in prostatic adenocarcinoma. Human Pathol 25: 92-97, 1994.
15. Theodorescu D, Broder SR, Boyd JC, Mills SE and Frierson HF Jr: p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate. J Urol 158: 131-137, 1997.
16. Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi SR, Tran QC, Hu SX, Xu HJ, Groshen S, Taylor CR, Skinner DG and Benedict WF: Elevated and absent pRb expression is associated with bladder cancel-progression and has cooperative effects with p53. Cancer Res 58: 1090-1094, 1998.
17. al-Abadi H, Nagel R and Neuhaus P: Immunohistochemical detection of p53 protein in transitional cell carcinoma of the bladder in correlation to DNA ploidy and pathohistological stage and grade. Cancer Detection Prevention 22: 43-50, 1998.
18. Dunn, MD, Stein JP, Shi S-R, Dickenson M, Taylor C, Skinner DG and Cote RJ: Retinoblastoma protein in bladder cancer: level of expression correlates with tumor progression. J Urol 157: 341A, 1997.